Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

778
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
778
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

588
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

718
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
718

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-Autonomous Defense against Tuberculosis.

Cold Spring Harbor perspectives in medicine·2026
Same author

Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

EMBO molecular medicine·2026
Same author

Genes required for <i>Mycobacterium tuberculosis</i> to survive the transition from aerosol to pulmonary alveolar lining fluid and early infection in a model of transmission.

bioRxiv : the preprint server for biology·2025
Same author

ACOD1-mediated lysosomal membrane permeabilization contributes to <i>Mycobacterium tuberculosis</i>-induced macrophage death.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Candidate transmission survival genome of <i>Mycobacterium tuberculosis</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferase.

Science advances·2024
Same journal

Morphotype-specific susceptibility to <i>Neosartorya</i> (<i>Aspergillus</i>) <i>fischeri</i> antifungal protein 2 is associated with an anabolic transcriptional signature in <i>Candida</i>.

Microbiology spectrum·2026
Same journal

High abundance of <i>Stenotrophomonas maltophilia</i> in slaty-backed gull breeding in Northern Japan.

Microbiology spectrum·2026
Same journal

Rhein reduces conjugation of IncFII-type plasmids in <i>Escherichia coli</i> and mitigates the spread of antibiotic resistance genes.

Microbiology spectrum·2026
Same journal

Phenotypic discordance in rifampicin resistance detection among <i>Mycobacterium tuberculosis</i> isolates from China: insights from whole-genome sequencing and a structured literature review.

Microbiology spectrum·2026
Same journal

Identification of protein secretion systems and type III effectors in wood-associated bacteria of the genus <i>Xylophilus</i>.

Microbiology spectrum·2026
Same journal

Intraspecific diversity of <i>Staphylococcus aureus</i> populations isolated from cystic fibrosis respiratory infections.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.2K

Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Ben Gold1, Carl Nathan1

  • 1Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065.

Microbiology Spectrum
|February 25, 2017
PubMed
Summary
This summary is machine-generated.

Host immunity creates conditions where Mycobacterium tuberculosis becomes tolerant to antibiotics. New high-throughput screening methods are needed to find drugs effective against non-replicating tuberculosis bacteria, reducing treatment duration and relapse rates.

More Related Videos

Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

24.5K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.2K
Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

24.5K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Host immunity influences Mycobacterium tuberculosis (Mtb) growth, creating niches that promote drug tolerance.
  • Non-replicating Mtb, a state induced by host microenvironments, exhibits significant tolerance to standard antibiotics.
  • This tolerance complicates tuberculosis treatment, leading to prolonged therapy and potential relapse.

Purpose of the Study:

  • To review methods for high-throughput screening (HTS) to identify compounds active against non-replicating Mtb.
  • To discuss strategies for advancing candidate molecules targeting persistent Mtb.
  • To highlight the urgent need for novel therapeutic approaches against drug-tolerant tuberculosis.

Main Methods:

  • Review of existing literature on HTS for identifying Mtb drug tolerance modulators.
  • Analysis of in vitro models simulating host-induced Mtb non-replicating states (e.g., nutrient starvation, hypoxia).
  • Classification of known bactericidal molecules against non-replicating Mtb based on structure and putative targets.

Main Results:

  • Host-derived microenvironments (hypoxia, acidic pH, nutrient starvation) induce profound Mtb drug tolerance.
  • Some current tuberculosis drugs (e.g., rifampin, bedaquiline) require higher concentrations to kill non-replicating Mtb in vitro.
  • A diverse range of pharmacophores have been reported to possess activity against non-replicating Mtb.

Conclusions:

  • Targeting non-replicating Mtb persisters is crucial for shortening treatment and preventing relapse.
  • Development of HTS assays and drug discovery pipelines is essential for finding effective agents.
  • Understanding the pharmacophore diversity of anti-persister compounds can guide future drug development efforts.